back-up series of MCH-1 antagonists (AMRI)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug Nameback-up series of MCH-1 antagonists (AMRI)
Drug Alias Nameback-up series of melanin concentrating hormone antagonists (AMRI)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionInsulin sensitizersMelanin-concentrating hormone receptor 1 inhibitors
TargetsMelanin-concentrating hormone receptor 1
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAlbany Molecular Research Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAlbany Molecular Research Inc
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A